The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
73823004 7382300 4 F 2006 20160708 20100510 20160715 EXP FI-PFIZER INC-2007078093 PFIZER 46.00 YR M Y 0.00000 20160715 LW FI FI

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
73823004 7382300 1 PS Champix VARENICLINE TARTRATE 1 Oral 0.5 MG, 1X/DAY Y 610257531 FI 21928 .5 MG FILM-COATED TABLET QD
73823004 7382300 2 I Champix VARENICLINE TARTRATE 1 Oral 0.5 MG, 2X/DAY Y 610257531 FI 21928 .5 MG FILM-COATED TABLET BID
73823004 7382300 3 I Champix VARENICLINE TARTRATE 1 Oral 1 MG, 2X/DAY Y 610257531 FI 21928 1 MG FILM-COATED TABLET BID
73823004 7382300 4 SS ZOLOFT SERTRALINE HYDROCHLORIDE 1 U 19839
73823004 7382300 5 I AMOXICILLIN TRIHYDRATE AMOXICILLIN 1 Oral UNK Y 0 TABLET
73823004 7382300 6 I AMOXICILLIN TRIHYDRATE AMOXICILLIN 1 Y 0 TABLET
73823004 7382300 7 I RINEXIN PHENYLPROPANOLAMINE 1 Oral 100 MG, UNK Y 0 100 MG
73823004 7382300 8 SS NICORETTE NICOTINE 1 4 MG, UNK Y 0 4 MG
73823004 7382300 9 SS NICORETTE NICOTINE 1 2 UNK, UNK Y 0 2 MG
73823004 7382300 10 SS NICORETTE NICOTINE 1 UNK U 0
73823004 7382300 11 SS SERTRALINE SERTRALINE HYDROCHLORIDE 1 50MG, 1/2 TABLET DAILY Y 0 QD
73823004 7382300 12 SS CIPRALEX ESCITALOPRAM OXALATE 1 UNK Y 0
73823004 7382300 13 SS METOCLOPRAMIDE. METOCLOPRAMIDE 1 U 0
73823004 7382300 14 C AZITHROMYCIN ANHYDROUS. AZITHROMYCIN ANHYDROUS 1 Oral 3 0
73823004 7382300 15 C DOXIMYCIN DOXYCYCLINE 1 Oral UNK 0
73823004 7382300 16 C KLACID CLARITHROMYCIN 1 Oral TEN DAYS COURSE 0
73823004 7382300 17 C HAVRIX HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) 1 Intramuscular UNK 0
73823004 7382300 18 C TOCLASE PENTOXYVERINE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
73823004 7382300 1 Nicotine dependence
73823004 7382300 5 Sinusitis
73823004 7382300 6 Influenza
73823004 7382300 8 Smoking cessation therapy
73823004 7382300 14 Influenza
73823004 7382300 15 Oropharyngeal pain
73823004 7382300 16 Acute sinusitis

Outcome of event

Event ID CASEID OUTC COD
73823004 7382300 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
73823004 7382300 Abdominal discomfort
73823004 7382300 Activities of daily living impaired
73823004 7382300 Acute sinusitis
73823004 7382300 Adjustment disorder with mixed anxiety and depressed mood
73823004 7382300 Adrenal insufficiency
73823004 7382300 Aggression
73823004 7382300 Agitation
73823004 7382300 Akathisia
73823004 7382300 Anxiety
73823004 7382300 Blood cholesterol increased
73823004 7382300 Blood glucose increased
73823004 7382300 Confusional state
73823004 7382300 Craniocerebral injury
73823004 7382300 Depression
73823004 7382300 Dizziness
73823004 7382300 Drug dependence
73823004 7382300 Drug interaction
73823004 7382300 Dyskinesia
73823004 7382300 Dyspnoea
73823004 7382300 Erectile dysfunction
73823004 7382300 Euphoric mood
73823004 7382300 Fatigue
73823004 7382300 Fear
73823004 7382300 Feeling abnormal
73823004 7382300 Feeling cold
73823004 7382300 Gastric disorder
73823004 7382300 Hallucination
73823004 7382300 Hepatic steatosis
73823004 7382300 Hyperhidrosis
73823004 7382300 Hypersensitivity
73823004 7382300 Hypopituitarism
73823004 7382300 Hyporeflexia
73823004 7382300 Hyposmia
73823004 7382300 Hypothyroidism
73823004 7382300 Increased appetite
73823004 7382300 Infection
73823004 7382300 Influenza
73823004 7382300 Irritability
73823004 7382300 Loss of libido
73823004 7382300 Lower respiratory tract infection
73823004 7382300 Memory impairment
73823004 7382300 Mood swings
73823004 7382300 Musculoskeletal discomfort
73823004 7382300 Nausea
73823004 7382300 Neurotoxicity
73823004 7382300 Nightmare
73823004 7382300 Obesity
73823004 7382300 Olfacto genital dysplasia
73823004 7382300 Palpitations
73823004 7382300 Panic reaction
73823004 7382300 Parkinson's disease
73823004 7382300 Personality change
73823004 7382300 Restlessness
73823004 7382300 Secondary hypogonadism
73823004 7382300 Sense of oppression
73823004 7382300 Sleep disorder
73823004 7382300 Snoring
73823004 7382300 Somnolence
73823004 7382300 Swelling
73823004 7382300 Tinnitus
73823004 7382300 Tremor
73823004 7382300 Upper respiratory tract infection
73823004 7382300 Vasodilatation
73823004 7382300 Vertigo
73823004 7382300 Weight increased
73823004 7382300 Withdrawal syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
73823004 7382300 1 20070702 20070704 0
73823004 7382300 2 20070705 20070708 0
73823004 7382300 3 20070709 20071108 0
73823004 7382300 5 20071105 20071108 0
73823004 7382300 7 20071105 200711 0
73823004 7382300 8 200603 2007 0
73823004 7382300 10 200603 0
73823004 7382300 11 20090305 0
73823004 7382300 12 20071218 0
73823004 7382300 14 20071024 200710 0
73823004 7382300 15 20071001 2007 0
73823004 7382300 16 20071111 200711 0
73823004 7382300 17 20070629 20070629 0
73823004 7382300 18 20071001 0